Gains May Be On The Menu For Rocket Pharmaceuticals Inc (NASDAQ: RCKT)
Currently, there are 106.45M common shares owned by the public and among those 99.07M shares have been available to trade. The company’s stock has a 5-day price change of -13.32% and -43.05% over the past three months. RCKT shares are trading -49.80% year to date (YTD), with the 12-month market performance down to -72.29% lower. […]
Rocket Pharmaceuticals Inc (NASDAQ: RCKT): The Best-Of-Breed For Investing?
Currently, there are 106.45M common shares owned by the public and among those 98.96M shares have been available to trade. The company’s stock has a 5-day price change of 36.33% and -37.39% over the past three months. RCKT shares are trading -48.05% year to date (YTD), with the 12-month market performance down to -73.01% lower. […]
Rocket Pharmaceuticals Inc (RCKT): Insights At A Glance
Rocket Pharmaceuticals Inc (RCKT) concluded trading on Wednesday at a closing price of $5.40, with 6.55 million shares of worth about $35.34 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -67.80% during that period and on April 09, 2025 the price saw a […]
Is Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Back In The Buying Zone?
Currently, there are 106.45M common shares owned by the public and among those 98.97M shares have been available to trade. The company’s stock has a 5-day price change of -28.89% and -50.55% over the past three months. RCKT shares are trading -53.78% year to date (YTD), with the 12-month market performance down to -78.43% lower. […]
